We are live on ! Find out more
CRB

Chad R. Baker Portfolio holdings

AUM $620M
1-Year Est. Return 42.67%
This Fund
S&P 500
This Quarter Est. Return
+8.73%
1 Year Est. Return
+42.67%
3 Year Est. Return
+108.31%
5 Year Est. Return
+132.07%
10 Year Est. Return
+563.15%
AUM
$301M
AUM Growth
+$19.7M
Cap. Flow
-$2.64M
Cap. Flow %
-0.88%
Top 10 Hldgs %
38.72%
Holding
58
New
2
Increased
3
Reduced
10
Closed
1

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$4.16M
2
ALC icon
Alcon
ALC
+$3.89M
3
AMZN icon
Amazon
AMZN
+$3.57M
4
ILMN icon
Illumina
ILMN
+$717K
5
ATR icon
AptarGroup
ATR
+$682K

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$5.87M
2
MA icon
Mastercard
MA
+$3.27M
3
BIIB icon
Biogen
BIIB
+$2.79M
4
PEP icon
PepsiCo
PEP
+$1.09M
5
PYPL icon
PayPal
PYPL
+$1.02M

Sector Composition

Rank Sector Weight
1 Healthcare 26.75%
2 Technology 17.73%
3 Industrials 16.76%
4 Communication Services 11.07%
5 Consumer Discretionary 8.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNI icon
51
Canadian National Railway
CNI
$77.6B
$825K 0.27%
9,125
WIRE
52
DELISTED
Encore Wire Corp
WIRE
$746K 0.25%
13,000
CDK
53
DELISTED
CDK Global, Inc.
CDK
$592K 0.2%
10,833
DD icon
54
DuPont de Nemours
DD
$18.5B
$549K 0.18%
6,808
DOW icon
55
Dow Inc
DOW
$21.9B
$468K 0.16%
8,546
CTVA icon
56
Corteva
CTVA
$58.5B
$253K 0.08%
8,546
SJM icon
57
J.M. Smucker
SJM
$12B
$221K 0.07%
2,125
BIIB icon
58
Biogen
BIIB
$30B
-11,995
Closed -$2.79M

Similar funds

Chad R. Baker's Q4 2019 Portfolio in Review

As of Q4 2019, Chad R. Baker held 58 positions worth $301M, up 7% from $281M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Chad R. Baker's Q4 2019 filing shows 2 new, 3 increased, 10 reduced and 1 closed positions. Its largest new stake was CVS Health: 59,180 shares worth $4.4M. The largest sale was Johnson & Johnson, an estimated $5.87M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 26% a quarter earlier, followed by Technology and Industrials.

  • Chad R. Baker's largest Q4 2019 buy was CVS Health: 59,180 shares worth $4.4M.
  • Chad R. Baker added most to Amazon in Q4 2019, an estimated $3.57M increase.
  • Chad R. Baker's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $5.87M.
  • Chad R. Baker fully exited Biogen in Q4 2019, selling an estimated $2.79M.
  • Chad R. Baker's ten largest holdings make up 39% of its $301M portfolio in Q4 2019.
  • Chad R. Baker opened 2 new positions and closed 1 in Q4 2019.
  • Chad R. Baker's portfolio value rose 7% quarter-over-quarter to $301M.

Based on Chad R. Baker's 13F filing for Q4 2019, filed 12 Feb 2020.